You need to enable JavaScript to run this app.
Euro Roundup: MHRA targets 150-day turn for priority, good quality drug dossiers
Roundups
Nick Paul Taylor
Europe
Pharmaceuticals
Quality Assurance and Control
RoundupsNick Paul Taylor
EuropePharmaceuticalsQuality Assurance and ControlRoundupsNick Paul TaylorEuropePharmaceuticalsQuality Assurance and Control